We are live on
!
Find out more
SGH
Sivik Global Healthcare Portfolio holdings
AUM
$132M
1-Year Est. Return
24.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.52%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$247M
AUM Growth
+$26.9M
(+12%)
Cap. Flow
+$1.99M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
28.64%
Holding
82
New
13
Increased
21
Reduced
29
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$5.2M |
| 2 |
Viatris
VTRS
|
+$4.79M |
| 3 |
Gilead Sciences
GILD
|
+$4.11M |
| 4 |
UnitedHealth
UNH
|
+$4.05M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.65M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$5.03M |
| 2 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$4.33M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.15M |
| 4 |
Cencora
COR
|
+$3.44M |
| 5 |
TMH
Team Health Holdings Inc
TMH
|
+$2.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.54% |
| 2 | Industrials | 0.78% |
| 3 | Energy | 0.75% |
Similar funds
RSF
VF
AFP
GCM
TCPW
GCM
FF
PF
Sivik Global Healthcare's Q4 2014 Portfolio in Review
As of Q4 2014, Sivik Global Healthcare held 82 positions worth $247M, up 12% from $220M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Sivik Global Healthcare's Q4 2014 filing shows 13 new, 21 increased, 29 reduced and 19 closed positions. Its largest new stake was Becton Dickinson: 40,693 shares worth $5.53M. The largest sale was Labcorp, an estimated $5.03M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Energy.
- Sivik Global Healthcare's largest Q4 2014 buy was Becton Dickinson: 40,693 shares worth $5.53M.
- Sivik Global Healthcare added most to Celgene Corp in Q4 2014, an estimated $3.3M increase.
- Sivik Global Healthcare's biggest Q4 2014 reduction was Cencora, cutting an estimated $3.44M.
- Sivik Global Healthcare fully exited Labcorp in Q4 2014, selling an estimated $5.03M.
- Sivik Global Healthcare's ten largest holdings make up 29% of its $247M portfolio in Q4 2014.
- Sivik Global Healthcare opened 13 new positions and closed 19 in Q4 2014.
- Sivik Global Healthcare's portfolio value rose 12% quarter-over-quarter to $247M.
Based on Sivik Global Healthcare's 13F filing for Q4 2014, filed 7 Jan 2015.